Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sugar-Coated Killer: Serotype 3 Pneumococcal Disease
Jennifer N. Luck, Hervé Tettelin, Carlos J. Orihuela
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 84

Showing 26-50 of 84 citing articles:

Serotypes and Antibiotic Resistance of Streptococcus pneumoniae before and after the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine for Adults and Children in a Rural Area in Japan
Takashi Ono, Masahiro Watanabe, Koichi Hashimoto, et al.
Pathogens (2023) Vol. 12, Iss. 3, pp. 493-493
Open Access | Times Cited: 9
Invasive pneumococcal disease surveillance in Canada, 2020
Alyssa Golden, Averil Griffith, Walter Demczuk, et al.
Canada Communicable Disease Report (2022) Vol. 48, Iss. 9, pp. 396-406
Open Access | Times Cited: 14
Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?
Daniel Jarovsky, Eitan Naaman Berezin
Jornal de Pediatria (2022) Vol. 99, pp. S46-S56
Open Access | Times Cited: 13
Streptococcus pneumoniae serotype 3 population structure in the era of conjugate vaccines, 2001–2018
Eleonora Cella, Catherine G. Sutcliffe, Lindsay R. Grant, et al.
Microbial Genomics (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 2
B cells in the pneumococcus-infected lung are heterogeneous and require CD4+ T cell help including CD40L to become resident memory B cells
Neelou Etesami, Kimberly A. Barker, Anukul T. Shenoy, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Characterization of Streptococcus pneumoniae isolates obtained from the middle ear fluid of US children, 2011–2021
Lindsay R. Grant, Kevin Apodaca, Lalitagauri M. Deshpande, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 2
Characteristics of children with invasive pneumococcal disease eligible for the 1+1 compared with the 2+1 PCV13 infant immunisation schedule in England: a prospective national observational surveillance study
Fariyo Abdullahi, Marta Bertran, Joshua C D'Aeth, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 11, pp. 788-797
Open Access | Times Cited: 2
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies
Ahmet Ozdilek, Jiachen Huang, Rachelle Babb, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 13
Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study
Andrea Orsi, Alexander Domnich, Stefano Mosca, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 70-70
Open Access | Times Cited: 9
Post-vaccine epidemiology of serotype 3 pneumococci identifies transformation inhibition through prophage-driven alteration of a non-coding RNA
Min Jung Kwun, Alexandru V. Ion, Hsueh-Chien Cheng, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Microbiological and clinical characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A multicenter observational study
Merve Arslan Aydin, Rajendra Prasad Janapatla, Chyi‐Liang Chen, et al.
Journal of Microbiology Immunology and Infection (2023) Vol. 56, Iss. 3, pp. 598-604
Open Access | Times Cited: 5
Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review
Kristen A. Feemster, Jessica Weaver, Ulrike K. Buchwald, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1750-1750
Open Access | Times Cited: 5
Influence of the Polysaccharide Capsule on the Bactericidal Activity of Indolicidin on Streptococcus pneumoniae
Natalha Tedeschi Waz, Sheila Knupp Feitosa de Oliveira, Raquel Girardello, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010–2019
Eiman Mokaddas, Shabeera Syed, M. John Albert
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4661-4666
Open Access | Times Cited: 11
Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age
Isis Kanevsky, Naveen Surendran, Kathleen McElwee, et al.
Vaccine (2023) Vol. 41, Iss. 45, pp. 6625-6629
Open Access | Times Cited: 4
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21
John J. Schellenberg, Heather J. Adam, Melanie Baxter, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 10, pp. 2653-2661
Open Access | Times Cited: 1
CC180 clade dynamics does not universally explain Streptococcus pneumoniae serotype 3 persistence post-vaccine: a global comparative population genomics study
Sydney Stanley, Catarina Silva-Costa, Joana Gomes-Silva, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Invasive Pneumococcal Diseases in People over 65 in Veneto Region Surveillance
Silvia Cocchio, Claudia Cozzolino, Andrea Cozza, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1202-1202
Open Access | Times Cited: 1
Non-invasive Streptococcus pneumoniae infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023
Ioannis Passaris, Stéphanie Depickère, Toon Braeye, et al.
Eurosurveillance (2024) Vol. 29, Iss. 45
Open Access | Times Cited: 1
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age
Susanna Esposito, Giulia Dal Canto, Maria Rosaria Caramia, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 1, pp. 45-51
Closed Access | Times Cited: 9
Pneumokokkenimpfstoffe
Mathias W. Pletz, Christina Bahrs
Der Internist (2021) Vol. 62, Iss. 8, pp. 807-815
Open Access | Times Cited: 9
The role of a single-shot higher-valency pneumococcal vaccine in overcoming challenges regarding invasive pneumococcal disease in Hong Kong
Christopher KM Hui, Ivan Fan‐Ngai Hung, Bing Lam, et al.
Hong Kong Medical Journal (2023)
Open Access | Times Cited: 3
Two putative glutamate decarboxylases of Streptococcus pneumoniae as possible antigens for the production of anti-GAD65 antibodies leading to type 1 diabetes mellitus
Ernesto Garcı́a
International Microbiology (2023) Vol. 26, Iss. 3, pp. 675-690
Open Access | Times Cited: 3
Impact of aluminum adjuvants on the stability of pneumococcal polysaccharide-protein conjugate vaccines
William J. Smith, Rachel Thompson, Patricia M. Egan, et al.
Vaccine (2023) Vol. 41, Iss. 35, pp. 5113-5125
Closed Access | Times Cited: 3
Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development
Haider Noori Dawood, Ali H. Al-Jumaili, Ahmed Radhi, et al.
F1000Research (2023) Vol. 12, pp. 435-435
Open Access | Times Cited: 3

Scroll to top